Lumax Industries Q1FY27: Consolidated PAT up 41% YoY to ₹51 Cr on 33% revenue growth
Lumax Industries reported consolidated revenue of ₹1,223.23 Cr for Q1 FY27 (quarter ended June 30, 2026), up 32.6% year-on-year from ₹922.52 Cr, with consolidated net profit rising 41.2% YoY to ₹51.08 Cr from ₹36.19 Cr. Sequentially, growth was far more muted — revenue grew just 1.9% and PAT fell 5.6% versus Q4 FY26's ₹1,200.32 Cr revenue and ₹54.10 Cr PAT, so the strength here is a YoY story riding a soft year-ago base rather than fresh sequential acceleration. Consolidated NPM expanded modestly to 4.18% from 3.91% a year ago, and calculated EBITDA margin was roughly flat at ~8.97% versus 8.87% YoY, though both margins are down from Q4's seasonally stronger ~4.51%/~10.2% levels. There were no exceptional items in either the current or year-ago quarter, so both the revenue and PAT YoY comparisons are clean with no adjustment needed.
The standalone entity tells a sharper story: standalone PAT surged 104.6% YoY to ₹51.99 Cr from ₹25.41 Cr, well ahead of the consolidated growth rate. The gap traces to the associate SL Lumax Limited, whose equity-accounted profit contribution to the Group fell 17.2% YoY to ₹11.25 Cr from ₹13.59 Cr, dragging consolidated growth below the standalone print. Relatedly, consolidated PAT (₹51.08 Cr) is actually marginally below standalone PAT (₹51.99 Cr) because consolidation strips out the ₹13.38 Cr dividend Lumax received from the associate (booked as standalone other income) and replaces it with the smaller ₹11.25 Cr equity-method profit share — a normal consolidation mechanic, not a result-quality issue. At the operating level, standalone PBT before exceptional items grew 92.3% YoY on 34.0% income growth against 31.8% expense growth, reflecting genuine operating leverage off a thin base margin.
No formal analyst consensus or brokerage preview for this specific quarter turned up in a web search — Lumax's earnings call with Chairman Deepak Jain and CFO Ravi Teltia is scheduled only for August 11, 2026, after this filing — so vs-Street is unknown rather than a scored beat or miss. Against management's own February 2026 guidance (revenue growth over 20% for FY27, double-digit EBITDA margins with a 12-13% two-year goal, backed by a ₹1,759 Cr order book), the quarter's 32.6% YoY revenue growth is already tracking well ahead of the >20% annual target, consistent with the bullish, confident tone management struck on that call. EBITDA margin of ~9%, however, remains short of the double-digit near-term goal, so margin build-out is still in progress even as the growth commitment is being beaten. No management press release or MD&A commentary accompanying this result was available to corroborate framing beyond the filed statements. The results were declared alongside routine governance items this quarter — the FY26 annual report/AGM notice dispatch and the August 26 AGM — none of which bear directly on the operating numbers.
Going into Q2 FY27, the print sets up three things to track: whether EBITDA margin progresses toward management's double-digit goal from the current ~9%, whether the associate SL Lumax's profit contribution recovers from this quarter's 17% YoY decline, and execution against the guided ₹100-150 Cr FY27 capex and the ₹1,759 Cr order book cited in February. The August 11 earnings call should provide updated commentary on all three.
